Scholarlink

<p>Withanolides are medicinally important steroidal lactones produced by <i>Withania somnifera</i> (ashwagandha), among other Solanaceae family plants, known for their neurological, anti-cancer and adaptogenic properties. However, the biosynthetic pathway to withanolides is largely unknown, preventing scale-up and hindering pharmaceutical applications. Here we generate a chromosome-scale assembly of the <i>W. somnifera</i> genome and identify two withanolide biosynthetic gene clusters that exhibit a segmented tissue-specific expression pattern. Using metabolic engineering in yeast, complemented by heterologous expression in <i>Nicotiana benthamiana</i> and virus-induced gene silencing in <i>W. somnifera</i>, we elucidate the withanolide biosynthetic pathway to an intermediate with all characteristic chemical features of withanolides. We report two cytochrome P450s (CYP87G1 and CYP749B2) and a short-chain dehydrogenase (SDH2) responsible for lactone ring formation. We additionally discover two P450s (CYP88C7 and CYP88C10) and a sulfotransferase (SULF1) that generate the characteristic A-ring structure of withanolides, featuring a C-1 ketone and C-2–C-3 unsaturation. Identifying SULF1 as a core pathway enzyme challenges the conventional paradigm of sulfotransferases as tailoring enzymes and suggests a wider role for this enzyme family in plant specialized metabolism. This work opens new avenues for the sustainable production of withanolides through biomanufacturing and for drug development leveraging the withanolide scaffold.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Elucidation of gene clusters underlying withanolide biosynthesis in ashwagandha through yeast metabolic engineering

  • 期刊论文

  • 发表日期：

    2026年1月30日

查看全文
  • Erin E. Reynolds,
  • Marena Trauger,
  • Fu-Shuang Li,
  • Jonathan Huang,
  • Trevor Moss,
  • Bastien Christ,
  • Menglong Xu,
  • Eva Knoch,
  • Jing-Ke Weng

摘要

Withanolides are medicinally important steroidal lactones produced by Withania somnifera (ashwagandha), among other Solanaceae family plants, known for their neurological, anti-cancer and adaptogenic properties. However, the biosynthetic pathway to withanolides is largely unknown, preventing scale-up and hindering pharmaceutical applications. Here we generate a chromosome-scale assembly of the W. somnifera genome and identify two withanolide biosynthetic gene clusters that exhibit a segmented tissue-specific expression pattern. Using metabolic engineering in yeast, complemented by heterologous expression in Nicotiana benthamiana and virus-induced gene silencing in W. somnifera, we elucidate the withanolide biosynthetic pathway to an intermediate with all characteristic chemical features of withanolides. We report two cytochrome P450s (CYP87G1 and CYP749B2) and a short-chain dehydrogenase (SDH2) responsible for lactone ring formation. We additionally discover two P450s (CYP88C7 and CYP88C10) and a sulfotransferase (SULF1) that generate the characteristic A-ring structure of withanolides, featuring a C-1 ketone and C-2–C-3 unsaturation. Identifying SULF1 as a core pathway enzyme challenges the conventional paradigm of sulfotransferases as tailoring enzymes and suggests a wider role for this enzyme family in plant specialized metabolism. This work opens new avenues for the sustainable production of withanolides through biomanufacturing and for drug development leveraging the withanolide scaffold.